Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2015

Jan 5, 2015

30597_dirs_2015-01-05_5ed56476-b6d4-487a-9f9f-5b2e6a32cd90.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2014-12-31

Reporting Person: LIDGARD GRAHAM PETER (Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-10-31 Common Stock A 459 $7.81 Acquired 185227 Direct
2014-12-08 Common Stock G 4000 Disposed 181227 Direct
2014-12-31 Common Stock M 6567 Acquired 187794 Direct
2015-01-02 Common Stock S 3363 $26.72 Disposed 184431 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-31 Restricted Stock Units $ M 6567 Disposed Common Stock (6567) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11395 Indirect

Footnotes

F1: Represents shares purchased through Employee Stock Purchase Plan.

F2: Represents shares of common stock received upon vesting of a restricted stock unit award.

F3: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain shares of restricted stock on December 31, 2014.

F4: Each restricted stock unit represents a contingent right to receive one share of common stock.

F5: Represents a restricted stock unit award granted on February 22, 2013 and earned on December 31, 2013 based on the satisfaction of certain performance-based vesting requirements. The restricted stock units vest in three equal annual installments beginning on December 31, 2013.